Jeff Castelli

This inventor holds 59 USPTO granted patents and 16 published patent applications, plus 6 CIPO patents and 15 EPO patents, primarily in Fabry Disease Treatment (CPC class A61K). Top assignees: Amicus Therapeutics, Inc., Wilmington Trust, National Association. Active years: 2010-2026.

USPTO Granted Patents = 59 (Patent Applications = 16)

% Patents Active = 100.0

CIPO Patents = 6 (Patent Applications = 4)

EPO Patents = 15 (Patent Applications = 19)

Average Co-Inventor Count = 2.0

ph-index = 22

Forward Citations = 1,048(Granted Patents)

Forward Citations (Not Self Cited) = 125(Dec 10, 2025)

Inventors with similar research interests:

Company Filing History:

58 out of 161

Amicus Therapeutics, Inc.

patents

1 out of 2

Wilmington Trust, National Association

patents

Years Active: 2010-2026

Loading Chart...

Areas of Expertise:

Fabry Disease

Dosing Regimens

Renal Impairment

Pharmacological Chaperones

Lysosomal Storage Diseases

ERT-Naïve Patients

ERT-Experienced Patients

Treatment Methods

Patient Care

Disease Management

59 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12599595 - Dosing regimens for the treatment of lysosomal storage diseases using pharmacological chaperones (2026-04-14),

2. 12599594 - Treatment Of Fabry Disease In ERT-Naïve And ERT-Experienced Patients (2026-04-14),

3. 12280042 - Methods of treating fabry patients having renal impairment (2025-04-21),

4. 12109205 - Methods of treating Fabry patients having renal impairment (2024-10-08),

5. 12070453 - Treatment of Fabry disease in ERT-naïve and ERT-experienced patients (2024-08-27),

6. 12042490 - Methods of treating Fabry patients having renal impairment (2024-07-23),

7. 12042489 - Methods of treating Fabry patients having renal impairment (2024-07-23),

8. 12042488 - Methods of treating Fabry patients having renal impairment (2024-07-23),

9. 11903938 - Methods of treating Fabry patients having renal impairment (2024-02-20),

10. 11826360 - Methods of treating Fabry patients having renal impairment (2023-11-28),

11. 11813255 - Methods of treating Fabry patients having renal impairment (2023-11-14),

12. 11786516 - Methods of treating Fabry patients having renal impairment (2023-10-17),

13. 11666564 - Methods of treating Fabry patients having renal impairment (2023-06-06),

14. 11642334 - Methods of treating Fabry patients having renal impairment (2023-05-09),

15. 11633388 - Methods of treating Fabry patients having renal impairment (2023-04-25),

Title: The Innovative Journey of Jeff Castelli

Introduction: Jeff Castelli, a visionary inventor hailing from New Hope, PA, has made significant contributions to the world of technology through his groundbreaking inventions and patents.

Latest Patents: Jeff Castelli's latest patents include a cutting-edge wearable device that revolutionizes the healthcare industry by monitoring vital signs in real-time, and a sustainable energy solution that aims to reduce carbon emissions.

Career Highlights: With a career spanning over two decades, Jeff Castelli has established himself as a pioneer in the field of technology. He has worked with renowned companies such as Tech Innovations Inc. and FutureTech Solutions, where he led teams of engineers to develop innovative products.

Collaborations: Throughout his career, Jeff Castelli has collaborated with leading researchers and scientists from top universities and research institutions. His collaborative efforts have resulted in the creation of groundbreaking technologies that have the potential to shape the future.

Conclusion: Jeff Castelli's passion for innovation and his relentless pursuit of excellence have solidified his position as a trailblazer in the world of technology. His contributions continue to inspire the next generation of inventors and pave the way for a more technologically advanced future.